ABOS - Acumen Pharmaceuticals partners with Lonza to advance sabirnetug for the treatment of Alzheimer's
2024-04-04 09:01:25 ET
More on Acumen Pharmaceuticals
- Acumen Pharmaceuticals, Inc. (ABOS) Q4 2023 Earnings Call Transcript
- Acumen Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Seeking Alpha’s Quant Rating on Acumen Pharmaceuticals
- Historical earnings data for Acumen Pharmaceuticals
- Financial information for Acumen Pharmaceuticals